D-0055-2025 Class II Ongoing

Recalled by Noven Pharmaceuticals Inc — Miami, FL

FDA drug recall D-0055-2025 was initiated by Noven Pharmaceuticals Inc on Oct 31, 2024 and is designated Class II. Reason for recall: Defective Delivery System: The product does not meet predetermined specifications for Coldflow (adhesive). The recall status is ongoing. Affected quantity: 685 boxes.

Recall details

Product Type
Drugs
Report Date
Nov 27, 2024
Initiation Date
Oct 31, 2024
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
685 boxes

Product description

Xelstrym (dextroamphetamine) transdermal system, 13.5 mg dextroamphetamine/9 hours, 30 individually sealed transdermal patches, inside a foil-sealed polypropylene tray, packed in a paper carton/box, MANUFACTURED BY NOVEN PHARMACEUTICALS, INC., Miami, FL 33186 United Sates, NDC 68968-0215-3

Reason for recall

Defective Delivery System: The product does not meet predetermined specifications for Coldflow (adhesive).

Distribution pattern

USA nationwide.

Code information

Lot # 95598, Exp 02/28/25

Source

Dataset
openFDA drug recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for D-0055-2025
openFDA file date
Nov 16, 2026
Loaded by RegDataLab
Nov 17, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for D-0055-2025. Report a data issue: hello@regdatalab.com.